Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Biogen Hammered As Lackluster Guidance Drags On Fourth-Quarter Beat
In This Article:
Biogen stock took a hit Wednesday after the biotech company issued light guidance for 2025 despite beating most fourth-quarter expectations.